Search Results

The Accu-Chek Compact Test Drums are used with the Accu-Chek Compact or Compact Plus Meter. The Accu-Chek Compact and Compact Plus system is designed to quantitatively measure the concentration of glucose in capillary and venous whole blood. The device is indicated for professional use and over-the-counter sale. The Accu-Chek Compact and Compact Plus system are indicated for lay person use with capillary whole blood samples drawn from the fingertips, forearm, upper arm, thigh, calf, and palm.

The ACCU-CHEK Compact Plus Blood Glucose Monitoring System consists of the ACCU-CHEK Compact Plus Meter, ACCU-CHEK Compact Test Strips (provided separately), ACCU-CHEK Compact Control Solutions (provided separately), ACCU-CHEK Softclix lancing device, and ACCU- CHEK Softclix lancets. The ACCU-CHEK Compact Plus meter and ACCU-CHEK Softclix lancing device are modifications of the ACCU-CHEK Compact meter and ACCU- CHEK Softclix lancing device, respectively. There are no changes to other system testing components compared to the currently marketed product.

The information provided states that the ACCU-CHEK® Compact Plus Blood Glucose Monitoring System is substantially equivalent to the ACCU-CHEK Compact Blood Glucose Monitoring System. The key claim is "There has been no change to the performance characteristics of the system. A comparison of system accuracy performance demonstrated that the ACCU-CHEK Compact Plus system and the currently marketed ACCU-CHEK Compact system are substantially equivalent. The system maintains compliance with EN ISO 15197."

However, the provided text does not include specific acceptance criteria or the detailed study results (like accuracy metrics, sample sizes, ground truth establishment, etc.) that would typically be expected to demonstrate compliance with acceptance criteria for a medical device. Instead, it relies on the assertion of "no change to the performance characteristics" and substantial equivalence to a predicate device that is compliant with EN ISO 15197.

Therefore, many of the requested details cannot be extracted directly from the provided text.

Here's a summary of what can and cannot be answered based on the provided document:

Acceptance Criteria and Reported Device Performance

Study Details

1. Sample size used for the test set and the data provenance:

   • Sample Size: Not specified for the study comparing the new device to the predicate.
   • Data Provenance: Not specified (e.g., country of origin, retrospective/prospective).

2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

   • Not specified. The document refers to "system accuracy performance" but does not detail how the ground truth reference values were obtained. For blood glucose measurements, this typically involves a laboratory reference method.

3. Adjudication method for the test set:

   • Not applicable as the ground truth is likely a quantitative lab measurement, not expert consensus requiring adjudication.

4. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

   • Not applicable. This is a blood glucose monitoring system, not an imaging or diagnostic device involving human readers/interpreters in the typical MRMC sense. The evaluation focuses on the accuracy of the device itself.

5. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

   • The evaluation described is inherently a standalone performance assessment of the device (meter and test strips) as it measures glucose concentration directly. The provided text, however, focuses on showing equivalence to the predicate device rather than detailing a new standalone performance study against a clinical reference.

6. The type of ground truth used:

   • While not explicitly stated, for blood glucose monitoring systems, the ground truth is typically established by laboratory reference methods (e.g., YSI 2300 STAT Plus Glucose & Lactate Analyzer) rather than expert consensus, pathology, or outcomes data.

7. The sample size for the training set:

   • Not applicable. Blood glucose monitoring systems are typically validated directly for accuracy against a reference method. There isn't a "training set" in the machine learning sense for these types of devices; rather, it refers to the sample size of patient measurements used in the clinical study. This sample size is not specified.

8. How the ground truth for the training set was established:

   • Not applicable as there is no training set in the machine learning sense. For the performance assessment, the ground truth would be established by a laboratory reference method.

Ask a specific question about this device